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Abstract 
Introduction: The mainstay of management for locally advanced rectal cancer is 
chemoradiotherapy followed by surgical resection. Following chemoradiotherapy, a complete 
response may be detected clinically and radiologically (cCR) prior to surgery or pathologically 
after surgery (pCR). We aim to report the overall complete pCR rate and the reliability of 
detecting a cCR by conventional pre-operative imaging. 
  
Methods: A pre-planned analysis of the European Society of Coloproctology (ESCP) 2017 audit 
was performed. Patients treated by elective rectal resection were included. A pCR was defined 
as a ypT0 N0 EMVI negative primary tumour; a partial response represented any regression 
from baseline staging following chemoradiotherapy. The primary endpoint was the pCR rate. 
The secondary endpoint was agreement between post-treatment MRI restaging (yMRI) and final 
pathological staging. 
  
Results: Of 2572 patients undergoing rectal cancer surgery in 277 participating centres across 
44 countries, 673 (26.2%) underwent chemoradiotherapy and surgery. The pCR rate was 10.3% 
(67/649), with a partial response in 35.9% (233/649) patients. Comparison of AJCC stage 
determined by post-treatment yMRI with final pathology showed understaging in 13% (55/429) 
and overstaging in 34% (148/429). Agreement between yMRI and final pathology for T-stage, N-
stage, or AJCC status were each graded as ‘fair’ only (n=429, Kappa 0.25, 0.26 and 0.35 
respectively). 
  
Conclusion: The reported pCR rate of 10% highlights the potential for non-operative 
management in selected cases. The limited strength of agreement between basic conventional 
post-chemoradiotherapy imaging assessment techniques and pathology suggest alternative 
markers of response should be considered, in the context of controlled clinical trials.  
What this study adds 
This paper highlights thea potential for selective non-operative management of rectal cancer 
with long-course chemoradiotherapy, highlighting a complete pathological response rate of 
10.3% in an international audit. There was limited agreement between basic conventional post-
chemoradiotherapy imaging and pathological staging, demonstrating a need for more sensitive 
markers of treatment response. 
  
Introduction 
Approximately 450 000 rectal cancers are diagnosed worldwide annually [1]. In developed 
countries, in which 55% of these diagnoses are made, 45-55% of electively managed patients 
will receive chemoradiotherapy prior to the cancer resection [2]. The surgical resection, 
performed according to the principles of total mesorectal excision (TME), is widely regarded as 
the mainstay of curative treatment for resectable rectal cancer [3]. However, rectal cancer 
resections have significant morbidity along with a 90-day mortality of approximately 4% - 5% [2, 
4]. Furthermore, the long-term consequences of treatment of pre-operative radiotherapy and 
surgery can profoundly impair quality of life, this may be attributed to bowel dysfunction 
following a restorative procedure [5, 6], living with the challenges and complications of a 
permanent stoma [7], or genitourinary side effects of treatment [8]. 
  
Over the past decade there has been increasing interest in avoiding the consequences of a 
TME procedure through organ preserving approaches [9, 10]. This is on the proviso that 
equivalent or favourable oncological outcomes can be achieved with a lower overall morbidity. 
One approach has been to consider deferral of surgery, whereby patients who have responded 
favourably to pre-operative chemoradiotherapy do not undergo surgery if there is no evidence of 
detectable tumour by clinical, endoscopic and radiological surveillance. These patients are 
diagnosed with a clinical complete response (cCR), this approach is also termed “Watch and 
Wait” or ‘Non-Operative Management [11, 12]. 
  
The original Watch and Wait concept was based on the observation of no residual tumour cells 
(a pathological complete response (pCR)) in up to 26.8% of rectal cancer specimens following 
chemoradiotherapy [10]. Furthermore, with optimal follow-up, selected patients who participate 
in these programmes were reported to have favourable oncological outcomes compared with 
patients who underwent surgery, with 5-year disease-free and overall survival exceeding 90% 
[10]. Deferral of surgery is increasingly reported as a feasible approach for rectal cancer 
management, with acceptable detection rates of regrowth and safe surgical salvage [13, 14]. A 
meta-analysis of 17 studies, from centres with established surveillance protocols for deferral of 
surgery, reported a clinical complete response rate (cCR) of 22.4% (95% CI:14.3–31.8) [15]. 
However most of these centres pursue strategies thought to enhance the likelihood of a 
favourable response, including consolidation or induction chemotherapy sensitizing regimes [16] 
radiotherapy dose escalation of up to 66Gy [17] and offering chemoradiotherapy to smaller 
tumours (over 25% of the tumours in the meta-analysis were cT2 or less) [15].  
  
The aim of this study was to record the complete pathological response rate reported in a ‘real 
world’ setting in order to determine the potential for widespread uptake of non-operative rectal 
cancer management. We also aimed to determine whether conventional radiological 
assessment of response to chemoradiotherapy is sufficiently reliable to feasibly consider 





This prospective, observational, multi-centre study was conducted in line with a pre-specified 
protocol (http://www.escp.eu.com/research/cohort-studies). An external pilot of the protocol and 
data capture system was conducted in five international centres prior to launch, allowing 




Any unit performing gastrointestinal surgery was eligible to register to enter patients into the 
study. No minimum case volume, or centre-specific limitations were applied. The study protocol 
was disseminated to registered members European Society of Coloproctology (ESCP), and 
through national surgical or colorectal societies. Units recruiting patients to rectal cancer trials 
were still eligible to participate in the study. 
  
Patient eligibility 
Adult patients (≥16 years) undergoing elective resection for rectal cancer treated with long-
course pre-operative chemoradiotherapy, with or without metastatic disease, were extracted 
from the main audit database. A rectal cancer was defined as an adenocarcinoma 0-15cm from 
the anal verge on rigid sigmoidoscopy or MRI. Concomitant chemoradiotherapy was a 
mandatory inclusion criteria, however the dose of chemotherapy and the delivery of long-course 
radiotherapy was administered to according to unit and clinician preference. Patients 




Consecutive sampling was performed for eligible patients over an 8-week study period in each 
included centre. Local investigators commenced data collection on any date between the 1 
February 2017 and 15 March 2017, with the last eligible patient being enrolled on 10 May 2017. 
Small teams of up to five surgeons or surgical trainees worked together to collect prospective 
data on all eligible patients at each centre. Quality assurance was provided by at least one 
consultant or attending-level surgeon. Data was recorded contemporaneously and stored on a 
secure, user-encrypted online platform (REDCap) without using patient identifiable information. 
Centres were asked to validate that all eligible patients during the study period had been 
entered, and to attain >95% completeness of data field entry prior to final submission. 
  
Demographic data including Age, Gender, American Society of Anaesthesiologists (ASA) 
classification grade, smoking history, body mass index, cardiovascular disease, indication for 
surgery and disease location. The index operation, operative steps, approach, duration and 
morbidity were recorded. Tumour staging information (T-stage, N-stage, extramural vascular 
invasion), recorded at three different timepoints, were available: 1. Baseline pre-neoadjuvant 
treatment MRI staging; 2. Post-treatment MRI staging; 3. Post-treatment pathological staging. 
Staging was summarised according to IUCC/AJCC TNM 7 system [18]. The MRI Rectum was 
performed according to individual unit protocol. An MRI for baseline staging was mandatory for 
all rectal cancers included in the study, the post treatment MRI was encouraged but was not 
compulsory. A complete pathological response (pCR) has been defined previously as ypT0,N0 
[19], our definition also required the ypEMVI status to be negative. Tumor regression was 
staged into three categories: a complete pathological response (no visible cancer cells), a 
partial response (regression from baseline MRI to pathology for one or more of T stage, N 
stage, EMVI status), and no change/progression from the baseline MRI staging. The 
circumferential rectal margin (CRM) was regarded as involved if the microscopic tumor 
Formatted: Keep with next
extension reached ≤1mm from the margin. Central quality control of surgical specimens by 
pathologic examination was not performed. 
  
Outcome measures 
The primary outcome measure was the rate of complete pathological response. The secondary 
outcome measure was the concordance of the TNM-based post-treatment MRI assessment and 
post-treatment pathological staging for T stage, N stage and overall AJCC TNM grade, 
assessed using Kappa agreement and the Intraclass Correlation Coefficient. 
  
Statistical analysis 
This report has been prepared in accordance to guidelines set by the STROBE (strengthening 
the reporting of observational studies in epidemiology) statement for observational studies [20]. 
Patient, disease and operative characteristics were compared using descriptive analysis and 
tests of normality were used to guide analysis. Chi-squared test was used for categorical data, 
Student’s t-test for normally distributed continuous data and Mann-Whitney U test for non-
parametric data. To explore associations between T-stage, nodal status, EMVI status and 
tumour height with pathological complete response univariable logistic regression models were 
fitted, described as odds ratios with 95% confidence intervals. 
  
The reliability of post-treatment MRI restaging to assess response to neoadjuvant therapy was 
assessed by the Kappa agreement between the post-treatment MRI and pathology T-, N- and 
AJCC-staging [21]. A Kappa value of <0.20 was interpreted as ‘Poor’, 0.21-0.40 as ‘Fair’, 0.41-
0.60 as ‘Moderate’, 0.61-0.80 as ‘Good’, and 0.81-1.00 as ‘Very good’. An estimate of the 
Intraclass Correlation Coefficient was also reported, with 95% exact confidence intervals (95% 
CI) derived using the variance components from a one-way ANOVA [22, 23].  Data analysis was 
undertaken using R Studio V3.1.1 (R Foundation, Boston, USA). 
  
Ethical approval 
All participating centres were responsible for compliance to local approval requirements for 
ethics approval or indemnity as required. In the UK, the National Research Ethics Service tool 
recommended that this project was not classified as research, and the protocol was registered 




Figure 1 shows inclusion of patients within this study. A total of 2572 patients underwent surgery 
for rectal cancer in 277 participating centres across 44 countries. Of these , 673 (26.2%) 
underwent CRT and TME surgery. Twenty four patients were excluded due to missing MRI or 
pathology staging.  The median (IQR) age of the remaining 649 patients was 65 years (56-71 
years). 35% (229/649) were female. 
  
pCR was reported in 10.3% (67/649) patients. An overall partial response occurred in 35.9% 
(233/649), with T stage regression in 42.8% (278/649), N stage regression in 71.6% of those 
with baseline node positivity (111/155), and EMVI regression in 82.5% with baseline mrEMVI 
positivity (33/40). No regression occurred in 53.8% (349/649) patients. Treatment failure with 
progression of T-staging was seen in 9.4% (53/562), N-staging in 8.9% (52/583) and EMVI-
status in 17.6% (99/561). 
  
Demographic and operative data are compared according to tumour response in Table 1. 
Overall the mean (SD) tumour height was 4.1cm [1.9], whereas the pCR group were 
significantly closer to the anal verge (mean (SD) 3.2cm [1.7], p<0.007). Patients with a pCR 
were more likely to undergo a restorative resection 73.1% (p=0.004) and a significantly higher 
proportion of robotic cases were performed on patients with a pCR (27%[13/48], p<0.001) 
compared with 11.4% [38/333] and 6.0% [16/268] for laparoscopic and open approaches, 
respectively. Response was not influenced by age, gender and patient fitness in this series. The 
degree of regression did not influence Clavien Dindo reported complication rates. 
  
Baseline MRI staging (n=649), post-CRT MRI staging (n=429), and pathological staging are 
compared against tumour response in Table 2. A post-treatment MRI was performed in 66.1% 
(429/649) of patients. According to the baseline MRI over 70% of tumours were T3 in all 
response groups, only 4.5% of pCR tumours were mrT4 and the highest proportion of T4 
tumours were in the partial response group 23.6% (55/233). mrT1 were reported in 8 (1.2%) 
cases, these were mrEMVI or mrN2 +ve tumours and all patients were non-responders. 
Following CRT, ymrT1 was reported in 7.7% overall and in 20% of pCR group. Figure 2 displays 
response rates by tumour height and pre-treatment MRI T-stage. Complete response was more 
common in T1/T2 tumours than T3/T4 tumours (14.5% versus 9.7%), although this association 
was non-significant (T3/T4; OR: 0.64, 0.34-1.30, p=0.19). Despite trends towards a higher pCR 
rate in low or middle rectal disease, neither tumour height (Low rectum; OR: 1.82, 0.76−5.43, 
p=0.22, Middle rectum; OR: 1.64, 0.65−5.02, p=0.33) or EMVI status (EMVI positive; OR: 1.26, 
0.42-3.07, p=0.64) were significantly associated with complete response. Node positivity at 
baseline was significantly associated with a lower rate of pCR (OR: 0.40, 0.17-0.81, p=0.02). 
  
The pathology data is also summarised in Table 2. There was no tumour in the pCR group and 
therefore the grade of differentiation could not be determined, however there was no difference 
in the tumour grade for partial and non-responders. Non-responders were significantly more 
likely than partial responders to be ypEMVI positive (12.9% [30/233] v 24.4% [85/349], 
p<0.001). The overall pCRM rate was 6.2% [40/649]. 
 
 The post-CRT MRI staging (n=429) is compared with pathology staging in Table 3. Overall 
understaging occurred in 14% (61/429) and 12.8% (55/429) of ypT stage and ypAJCC grade 
cancers respectively. Overstaging was reported in 35% (151/429) of ypT staging and 34% 
(148/429) of ypAJCC grading. Table 4 shows that the agreement between the post-treatment 
MRI and Pathology was graded ‘fair’ for T stage, N stage and AJCC status (Kappa 0.25, 0.26 




This large, prospective international audit identified a pCR rate of 10.3% for patients with rectal 
cancer treated with preoperative chemoradiotherapy. This data was simultaneously collected 
from 262 units over a period of six weeks. It provides a unique and truly generalised ‘snapshot’ 
of the pathological response rate in current practice. Many regard a pathological response as a 
mixed blessing; on the one hand this reflects a favourable prognosis but on the other it may 
indicate an unnecessary operation with the sequelae that can follow. Consequently, there is 
increasing interest in trying to identify a pCR after chemoradiotherapy on clinical and 
radiological grounds rather than by pathological assessment. However, this ‘real-world’ MRI 
staging data gives us an indication that if current basic staging tools are used in isolation, they 
will be inadequate for accurately identifying and safely monitoring deferral of surgery patients. 
  
The pCR rate reported in this study is consistent with rates in large trials that used single agent 
concomitant chemotherapy and a radiotherapy dose of ≥45Gy. The FFCD 9203, EORTC 22921 
and the German Rectal Cancer Study (CAO/ARO/AIO-94) trials have been described 
extensively elsewhere they recruited cT3 or resectable cT4M0 adenocarcinoma of the rectum, 
located within 15cm, 15cm and 16cm of the anal verge respectively [24-26]. These trials 
reported pCR rates with pre-operative CRT of 11.4%, 14% and 8% respectively [24-26]. One 
review of phase II and III studies identified pCR rates ranging from 0-67% with an overall pCR 
rate of 13.5% [27]. 
  
This current study identified that a pCR was associated with a lower tumour height. This finding 
has been reported previously and authors postulate that lower tumours are fixed by the pelvic 
floor muscles allowing radiotherapy to be delivered more consistently which allows for a 
favourable response rate [28]. A significantly higher proportion of patients in the pCR group had 
a node negative tumour at baseline. As authors have previously discussed, this may indicate 
that earlier stage tumours are more likely to produce a complete clinical response or this may 
reflect a more biiologically indolent tumour that is more likely to respond favourably to treatment 
[15,28-29]. The size of the tumour may also influence complete response rates [29], however in 
this study tumours were predominately mrT3 and the MRI baseline staging suggested CRT was 
given in order to downstage locally advanced tumours rather than to achieve a complete 
response in early stage tumours. 
  
Other factors previously shown to be associated with an increased response rate include dual 
concomitant chemotherapy [27], induction chemotherapy [30], consolidation chemotherapy [31, 
32], allowing time for regression between CRT and surgery [33], and intensified pre-operative 
radiotherapy [17]. The pathological assessment can also influence the pCR rate, and a thorough 
pathologist is less likely to identify a pCR. However recent guidelines for assessing post-CRT 
rectal cancer specimens provide recommendations on the number of levels that should be cut 
from each tumour block and these are likely to standardise the pathological assessment of 
response [34]. 
  
Enhancing the response to CRT and achieving a pCR is an encouraging outcome and many 
patients with a pCR will be reassured by the absence of a cancer. The long-term outcomes are 
highly favourable; the German Rectal Cancer trial reported a 10 year DFS of 89.5% a pCR, 
compared with 63% for poor responders (p=0.008) [35]. On the other hand this represents a 
missed opportunity for organ preservation. In selected patients it is possible to avoid surgery. 
Thus much of the morbidity may be prevented along with the reported 90-day post-operative 
mortality of 4% - 5% [4]. Deferral of surgery has now been reported for 867 patients from 23 
studies [13]. In highly selected cases, motivated centers with established protocols for deferral 
of surgery, report no significant difference between ‘deferral of surgery’ versus a clinical 
complete response in terms of non-regrowth recurrence (RR 0.58, 95% CI 0.18-1.90), disease-
free survival (HR 0.56, 95% CI 0.20-1.60), or overall survival (HR 3.91, 95% CI 0.57-26.72) [13]. 
  
The challenge that currently prevents widespread uptake of ‘deferral of surgery’ is the inability to 
reliably identify and monitor responders. In our study ‘fair’ Kappa agreements of 0.25, 0.26 and 
0.35 were reported for ypT stage, ypN stage and ypAJCC grade respectively with understaging 
occurred in over 10% of cases and overstaging in over 30% of cases. These Kappa agreements 
exceed published agreements for other methods of assessing response such as mrRECIST 
[Response Evaluation Criteria In Solid Tumors] criteria and MR volumetric analysis (Kappa 0.12 
and 0.36 respectively) [36]. However higher Kappa agreement scores of >0.4 have been 
reported for ymr versus pT stage assessment in selected centres [36]. Nevertheless, these data 
suggests that in a the techniques used in a typical international surgical unit for post-treatment 
MRI staging areis insufficiently reliable to allow for the safe delivery of deferral of surgery.  
 
In selected centres, multidisciplanry team (MDT) orientated standardised protocols have 
contributed to significant improvements in the interpretation of imaging modalitiesresponse to 
chemoradiotherapy;  have been achieved, whereby multimodal assessment, which  of the 
response of the primary tumourincludes clincal and endoscopic examinations, are  is performed 
and T2-with MRI usually serves as the primary screening tool in the assessment of response 
[376-398]. This suggests that with optimal training and experience, current tools can be used 
effectively to select patients whose tumours have responded favourably to chemoradiotherapy. 
Nnevertheless in a global setting we share the view of the authors of the MERRION study 
[4039] and Putte et al who suggested current imaging modalities have a lowthe poor accuracy 
of current imaging modalities forto predicting  a true pathological complete response, suggest 
indicating that this strategydeferral of surgery should not be offered outside of well-designed 
controlled clincal trialss [410]. 
  
The actively recruiting TRIGGER randomised control trial is testing methods to identify, and 
safely monitor, clinical complete responders [421]. The trial identifies clinical complete 
responders by applying a 5-point MRI tumour regression grade (mrTRG), which most closely 
resembles the Mandard pathologic pTRG system [398]. The basic principle of both grading 
systems relate to the ratio of tumour to fibrosis following CRT. This is the first imaging technique 
that has been shown to assess the degree of tumour regression and to correlate the findings 
with pathology and with long-term survival [376, 432]. A unique aspect of this trial is that 
participating units are trained to report mrTRG and may only take part when the unit radiologist 
completes a training dataset for mrTRG and achieves a high degree of agreement with the 
index radiologist (Kappa ≥ 0.7) [421]. This trial may enable the dissemination of a standardised, 
reliable, evidence based techniques for assessing post-chemoradiotherapy response.  
  
There are a number of limitations with this study. There is a lack of detail in terms of treatment 
approach. We did not know the exact radiotherapy dose used, whether pre-operative 
‘consolidation' or ‘induction' systemic chemotherapy was used in addition to CRT or the 
standard waiting time between completion of CRT (or short course radiotherapy) and surgery. 
Consequently we have not been able to perform a multivariate analysis to explore the key risk 
factors for predicting a favourable response to CRT. Although it was compulsory for data to be 
reviewed by a senior member of the department prior to submission, no external audit of the 
radiology or pathology was performed and we could not be certain that recogised standardised 
methods were performed [34,42]. For the purposes of this study we believe this to be 
acceptable because it simply reflects the ‘real-world’ data that we aimed to assess. Finally, only 
patients undergoing surgery were included in the study. It is possible that a number of units 
already practice deferral of surgery. However, for the reasons outlined above we would 
recommend that this is performed within the context of a clinical trial. 
 Conclusions 
The pathological complete response (pCR) rate of 10% reported in this international audit is 
consistent with rates reported in clinical trials that used concomitant chemoradiotherapy. This 
highlights the potential for non-operative management in selected rectal cancer patients, 
however the number of eligible patients may be increased if treatment strategies that enhance 
the overall response rate are pursued. The second barrier to non-operative management is the 
limited strength of agreement between post-CRT imaging and pathology. This suggests that 
assessing response with crude measures such as post-treatment T stage and post-treatment 
AJCC grade are not reliable or generalisable. Alternative detection methods, such as mrTRG 
with serial assessment, need to be considered in the context of clinical trials in order to feasibly 
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